Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2024

Type / Class
Equity / American Depository Shares, each of which represent twenty ordinary shares, no par value
Symbol
GLTO on Nasdaq
Shares outstanding
6,111,111
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Otto Erik 6.3% -22% 385,000 -77% Otto Erik 10 Feb 2026
Ikarian Capital, LLC 22% 285,710 Ikarian Capital, LLC 30 Nov 2025

Institutional Holders of Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$1,904,041 0
2024 Q2 4,036,280 $1,914,098 -$7,306 $0.47 20
2024 Q1 3,955,560 $3,086,219 +$84,662 $0.78 24
2023 Q4 3,850,203 $2,771,751 -$1,147,867 $0.72 19
2023 Q3 5,447,043 $3,919,925 -$6,230,492 $0.72 21
2023 Q2 10,195,650 $25,692,234 +$3,108,586 $2.52 27
2023 Q1 8,962,608 $17,835,944 +$164,580 $1.99 25
2022 Q4 8,879,970 $10,210,816 -$425,605 $1.15 22
2022 Q3 9,162,327 $17,316,000 +$113,505 $1.89 25
2022 Q2 9,102,298 $15,746,000 -$1,143,010 $1.73 21
2022 Q1 9,565,150 $21,044,000 -$1,247,710 $2.20 24
2021 Q4 10,056,300 $30,470,000 -$1,059,530 $3.03 24
2021 Q3 10,398,274 $37,206,000 -$5,044,237 $3.59 25
2021 Q2 11,371,502 $57,371,000 -$12,450,152 $5.06 24
2021 Q1 13,693,226 $82,938,000 -$3,196,797 $6.07 17
2020 Q4 14,108,246 $174,674,000 +$174,674,000 $12.50 19